Wendy Diller

Senior Writer/Market Analyst

20 Years of Experience

About

Wendy writes on the medical devices and clinical diagnostics sectors, where she focuses on orthopedics/spine, molecular diagnostics and personalized medicine, clinical genomics, womens’ health/ femtech, and reimbursement/commercial strategy and innovation related to these specialties. She welcomes and encourages ideas and input from members of the MedTech Strategist Community.

Her career spans more than 20+ years as a top writer and manager focused on qualitative analysis of the global life sciences industry. She is Chair of Young Women in Bio Metro NY, an organization devoted to encouraging secondary students in the NY area to pursuit STEM careers and on the board of the Columbia Business School of Alumni Club NY

Specialties
Publications
Articles from Wendy Diller:
Read all from this author
Investors & Dealmaking

Healthcare Data is Driving Medtech Strategy: What Dealmakers Need to Know

  • 2026-01-27 00:00:00.0
  • Wendy Diller
  • MedTech Strategist

Access to data and the use of it are increasingly important components of corporate strategy. How it is valued, structured and owned differentiates companies and raises challenges in dealmaking. A panel organized this month by Medtech Strategist for Weill Cornell Medicine’s BioVenture eLab Accelerator sought clarity, and an innovative, focused venture capitalist separately gives her firm’s creative investment thesis.

Read Article